The Board of Directors of Hanall Biopharma Co.,Ltd has authorized a buyback plan on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,350 KRW | -0.45% | +0.45% | -24.72% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.72% | 1.24B | |
+48.53% | 779B | |
+40.67% | 631B | |
-6.37% | 354B | |
+20.93% | 333B | |
+8.21% | 301B | |
+16.75% | 249B | |
-1.19% | 216B | |
+10.85% | 214B | |
+4.40% | 163B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Hanall Biopharma Co.,Ltd authorizes a Buyback Plan.